Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men

NCT01403116 is registered in ClinicalTrials.gov with Clarus Therapeutics, Inc. as lead sponsor.

NCT NCT01403116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01403116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Lead sponsor
Clarus Therapeutics, Inc.
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2011
Completion date
September 30, 2013
Enrollment
325 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

male hypogonadism